ArticleScientific reports2025
Vamp8 modulates cerebral ischemia-reperfusion injury via the autophagy-lysosome pathway.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Exploring the molecular mechanism of dexmedetomidine in alleviating blood-brain barrier disruption in rats with cerebral ischemia reperfusion injury based on network pharmacology.Frontiers in molecular neuroscience · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Lysosomal autophagy plays a critical role in ensuring the continuity of autophagic flux, however bioinformatics studies investigating biomarkers associated with lysosomal autophagy in cerebral ischemia-reperfusion injury(CIRI) remain scarce. Three datasets (GSE61616, GSE97537, and GSE82146) were retrieved from the GEO database. After batch correction, GSE61616 and GSE97537 were integrated into a combined dataset, while GSE82146 served as the validation set. Lysosomal autophagy-related genes (LRGs) obtained from the GeneCards database were intersected with differentially expressed genes (DEGs) identified between the CIRI group and the control group, resulting in the identification of 36 lysosomal autophagy-related differentially expressed genes (LRDEGs). Functional enrichment analysis using Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), and Gene Set Enrichment Analysis (GSEA) revealed that LRDEGs are primarily involved in biological processes such as membrane fusion and SNARE binding and are significantly enriched in inflammation-related pathways. We built a diagnostic model for CIRI and identified the biomarkers Vamp8. The results were further validated by quantitative real-time PCR (qPCR) and Western blotting. Simultaneously, immune infiltration analysis was performed. Finally, the mRNA-miRNA and mRNA-RBP interaction regulatory networks of the key genes revealed that Vamp8 is regulated by miR-325-3p, Elavl1, Zfp36, and Pabpc1.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.